Products compared on real EPA and DHA content, form, verification, transparency, and value.
Why omega-3 matters for GLP-1 users
The American Heart Association recommends about 1 g/day combined EPA+DHA for people with elevated cardiovascular risk — a population that substantially overlaps with people prescribed a GLP-1 for weight or metabolic reasons.
What matters on the label is the actual combined EPA+DHA milligrams, not the total "fish oil" weight — a large share of a fish-oil capsule's weight can be inert filler oil that contributes nothing.
We score every omega-3 product the same way: how well-dosed it is against a clinical reference amount, whether the form is a good one, whether an independent lab has verified what's on the label, how clearly the label discloses every ingredient, and price per effective dose. On top of that, we add one GLP-1-specific check — for omega-3, that means checking the actual combined EPA+DHA amount, not just the total "fish oil" weight, plus whether an independent lab has tested the product for freshness. Every score is public and reproducible from the same two data sources anyone can check.
438 products scored · Insyder Score v0.3 · last scored 2026-07-16 · how scoring works →
GOOD TO KNOW
Frequently asked questions
Best omega-3 supplement on a GLP-1
We score omega-3s primarily on actual EPA+DHA milligrams per serving (not total "fish oil" mg, which can be mostly inert filler oil) against the clinical reference floor, plus third-party oxidation testing (IFOS) as part of the verification axis. Full methodology, axis weights, and changelog: /glp-1-supplements/methodology/.
Fish oil while on Ozempic — worth it and which brand?
We don't make a blanket "worth it" call — that's a prescriber conversation. What we score is comparability: EPA+DHA dose, form, third-party verification, and label transparency across every candidate, side by side. Full methodology, axis weights, and changelog: /glp-1-supplements/methodology/.